Pentacare Jan 2018 Quiz!!!!!!!!

20 Questions | Total Attempts: 114

SettingsSettingsSettings
Pentacare Jan 2018 Quiz!!!!!!!! - Quiz

.


Questions and Answers
  • 1. 
    Neurotransmitter is stored in:-
    • A. 

      Vessels

    • B. 

      Cell body

    • C. 

      Vesicles

    • D. 

      Nucleus

  • 2. 
    Function of basal ganglia is __________
    • A. 

      Emotions

    • B. 

      Memory

    • C. 

      Motor coordination

    • D. 

      Language

  • 3. 
    Process of breaking of tablets into small particles is called__________
    • A. 

      Absoprtion

    • B. 

      Disintegration

    • C. 

      Dissolution

    • D. 

      Metabolism

  • 4. 
    The coverage strategy for Pentacare is
    • A. 

      20 doctors – 3 visits, 20 Doctors -1 visit and 60 doctors – 2 visits

    • B. 

      20 doctors – 4 visits, 20 Doctors -1 visit and 60 doctors – 2 visits

    • C. 

      20 doctors – 4 visits, 10 Doctors -1 visit and 70 doctors – 2 visits

    • D. 

      10 doctors – 4 visits, 30 Doctors -1 visit and 60 doctors – 2 visits

  • 5. 
    If a tetra core doctor (4 Visit) is met 3 times in a month:
    • A. 

      He will be considered for total coverage

    • B. 

      He will not be considered for VF Coverage

    • C. 

      He well be considered for both Total Coverage and VF Coverage

    • D. 

      Both A & B

  • 6. 
    If a Core doctor (2 Visit) is met 3 times in a month
    • A. 

      He will be considered for total coverage

    • B. 

      He will not be considered for VF Coverage

    • C. 

      He well be considered for both Total Coverage and VF Coverage

    • D. 

      He will not be considered for total coverage

  • 7. 
    Unique Features of  DONApp highlighted in VA are
    • A. 

      Patient tracker

    • B. 

      Know about Dementia & Alzheimers

    • C. 

      Appointment reminders

    • D. 

      Photo album

    • E. 

      All of the above

  • 8. 
    Combination therapy of Donep – M /M forte provides greater improvement over monotherapy in terms of
    • A. 

      A. Cognitive functions

    • B. 

      B. Behavioural and Psychological Symptoms of dementia

    • C. 

      C. Global Functions

    • D. 

      D. All of the above

    • E. 

      E. Both B & C

  • 9. 
    I remember dispenser contains 
    • A. 

      A. PEL- containing information on personal hygiene

    • B. 

      B. PEL – containing information on personal hygiene and care of Dementia and Alzheimer’s patients

    • C. 

      C. Memory test

    • D. 

      D. Both B and C

  • 10. 
    Donep plain & combination is targeted against which of the following specialities     (As per cycle meet strategy)
    • A. 

      A. Donep M - Neurologists & Donep - Psychiatry

    • B. 

      B. Donep – Neuros & Donep M - Psychiatry

    • C. 

      C. Donep M – Neuro & Donep M - CPs

    • D. 

      D. None of the above

  • 11. 
    Latest update in the facebook community was on which topic
    • A. 

      A. On father & son relationship

    • B. 

      B. On mother & daughter relationship

    • C. 

      C. Memories of childhood friendship

    • D. 

      D. Differences between old age symptoms Vs Dementia symptoms

  • 12. 
    Identify the right indications which will suit Neurokem OD
    • A. 

      A. Maintainance phase of NeP

    • B. 

      B. Working class of patients with NeP

    • C. 

      C. Mild to moderate conditions of Nep

    • D. 

      D. All of the above

  • 13. 
    If a CP sees about 20-25 patients/day and he is Rxers monthly 5 boxes of gabapentin. Can we select him to conduct NeP camp?
    • A. 

      Yes

    • B. 

      No

    • C. 

      Will think about it

    • D. 

      None of the above

  • 14. 
    MRP of Neurokem OD is _________
    • A. 

      130 rupees/ Strips of 10 Tablets

    • B. 

      115 rupees/ Strips of 10 Tablets

    • C. 

      122 rupees/ Strips of 10 Tablets

    • D. 

      110 rupees/ Strips of 10 Tablets

  • 15. 
    Targeted PMPM for Neurokem OD is
    • A. 

      25000

    • B. 

      20000

    • C. 

      30000

    • D. 

      15000

  • 16. 
    The highlighting points of Valkem OD Video are
    • A. 

      All the points mentioned below

    • B. 

      OD tablets if broken doesn’t give 24 hour protection

    • C. 

      Patients prefer smaller, oval shaped and white tablets

    • D. 

      Valkem OD uses HPMC technology

    • E. 

      D. Alu-Alu packing doesn’t allow swelling of tablets due to moisture

  • 17. 
    Which is not a benefit of Alu Alu Packing:
    • A. 

      A. Resistance from light and moisture

    • B. 

      B. Ensures stability during formulation

    • C. 

      C. No cavity

    • D. 

      D. Ensures stability post formulation

  • 18. 
    Lacosamide ( Sizlac) is approved as monotherapy by European Medical Agency for
    • A. 

      A. POS in adults

    • B. 

      B. POS in children above 2 years of age, adults and adolescent

    • C. 

      C. POS in adolescent

    • D. 

      D. POS in adults, adolescent and children from 4 years of age

  • 19. 
    The advantages of Lacosamide inj (Sizlac) in SE are
    • A. 

      Offers high response rate of 57% as a monotherapy

    • B. 

      Lack of drug-drug interaction potential

    • C. 

      Both the above

    • D. 

      None of the above

  • 20. 
    MRP of Sizlac inj is _______
    • A. 

      203

    • B. 

      198

    • C. 

      183

    • D. 

      193

Back to Top Back to top